Three posts from the editorial desk
Each takes one finding and turns it into something you can use elsewhere.
Published August 29, 2026
One is a nerve being squashed. The other is a nerve being poisoned by high blood sugar. Nearly every study you will be shown is about the second. Two words used as if they meant the same thing. They describe different problems with different causes, and nearly all the research is about one of them.
Why it is here. It is the finding that underpins the whole of this site. The best-evidenced ingredient in this bottle has been studied in diabetic neuropathy, and sciatica is mechanical compression of a nerve root. Read it before you read any study anybody sends you.
Published September 10, 2026
The most persuasive words on most supplement packaging are the ones nobody had to substantiate. A supplement label is regulated wording. A product name is not. Here is what the difference lets a brand say without ever printing a claim.
Why it is here. A product named after a diagnosis is the most important thing to understand about this bottle. The post generalises it: label wording is regulated, product names are not, and the gap between the two is where a great deal of persuasion happens.
Published September 20, 2026
Four hundred milligrams, then one hundred and fifty, then a cliff. On a label that prints every amount, the formula splits in two: the rows doing work, and the rows lengthening the list. Here is how to spot the join.
Why it is here. Because this label prints every amount, it is a rare chance to watch the split happen in public: 400 mg, then 150 mg, then 50 mg, then three rows at 25 mg. The post shows how to find the join on any panel, including the ones that hide it behind a blend total.